Literature DB >> 12099948

A quantitative and qualitative pilot study of the perceived benefits of autogenic training for a group of people with cancer.

S Wright1, U Courtney, D Crowther.   

Abstract

This paper describes the application of autogenic training (AT), a technique of deep relaxation and self-hypnosis, in patients diagnosed with cancer,with the aim of increasing their coping ability, and reports the results of a questionnaire survey performed before and after an AT course. A reduction in arousal and anxiety can help individuals to perceive their environment as less hostile and threatening, with implications for improved perceived coping ability. Complementary therapies are considered useful in enhancing symptom relief, overall well-being and self-help when used as adjuvant therapies to allopathic medical interventions. The present study aimed to validate, in an Irish context, the effectiveness of AT as a complementary therapy for patients with cancer. Each participant completed a Hospital Anxiety and Depression Scale and Profile of Mood States questionnaire before and after a 10-week AT course. The results indicated a significant reduction in anxiety and increase in 'fighting spirit' after compared with before training, with an improved sense of coping and improved sleep being apparent benefits of AT practice.

Entities:  

Mesh:

Year:  2002        PMID: 12099948     DOI: 10.1046/j.1365-2354.2002.00307.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  2 in total

1.  Relaxation training for anxiety: a ten-years systematic review with meta-analysis.

Authors:  Gian Mauro Manzoni; Francesco Pagnini; Gianluca Castelnuovo; Enrico Molinari
Journal:  BMC Psychiatry       Date:  2008-06-02       Impact factor: 3.630

2.  The process of learning the autogenic training relaxation technique and its benefits on the wellness of people living with HIV.

Authors:  Maria Pilar Ramirez Garcia; Jérôme Leclerc-Loiselle; José Côté; Marie-Josée Brouillette; Réjean Thomas
Journal:  BMC Complement Med Ther       Date:  2022-03-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.